Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Nussbaumstr.7, 80336, Munich, Germany.
Department of Psychological Methodology and Assesssment, Ludwig Maximilian University of Munich, Leopoldstr. 13, 80802, Munich, Germany.
Eur Arch Psychiatry Clin Neurosci. 2020 Sep;270(6):699-708. doi: 10.1007/s00406-020-01118-x. Epub 2020 Apr 3.
Neuropsychological functioning turns out to be a rate-limiting factor in psychiatry. However, little is known when comparing neuropsychological and psychosocial functioning in inpatients with schizophrenia or severe depression in their treatment pathways including add-on psychoeducation or the latter combined with cognitive behavioral therapy up to 2-year follow-up. To evaluate this question, we investigated these variables in two randomised controlled trials including 196 patients with DSM-IV schizophrenia and 177 patients with major depression. Outcome measures were assessed in the hospital at pre- and posttreatment and following discharge until 2-year follow-up. We focused on neuropsychological and psychosocial functioning regarding its differences and changes over time in data of two pooled trials. There were significant time effects indicating gains in knowledge about the illness, short and medium-term memory (VLMT) and psychosocial functioning (GAF), however, the latter was the only variable showing a time x study/diagnosis interaction effect at 2-year follow-up, showing significant better outcome in depression compared to schizophrenia. Moderator analysis showed no changes in psychosocial and neuropsychological functioning in schizophrenia and in affective disorders due to age, duration of illness or sex. Looking at the rehospitalisation rates there were no significant differences between both disorders. Both groups treated with psychoeducation or a combination of psychoeducation and CBT improved in neuropsychological and psychosocial functioning as well as knowledge about the illness at 2-year follow-up, however, patients with major depression showed greater gains in psychosocial functioning compared to patients with schizophrenia. Possible implications of these findings were discussed.
神经心理学功能在精神病学中是一个限制因素。然而,当比较精神分裂症或严重抑郁症患者在治疗途径中的神经心理学和心理社会功能时,包括附加心理教育或后者与认知行为疗法相结合,直到 2 年随访时,知之甚少。为了评估这个问题,我们在两项随机对照试验中调查了这些变量,共纳入 196 例 DSM-IV 精神分裂症患者和 177 例重性抑郁症患者。在住院前、治疗后和出院后至 2 年随访期间评估了结果测量。我们关注神经心理学和心理社会功能,因为它在两项合并试验的数据中存在差异和随时间变化。有显著的时间效应表明在疾病知识、短期和中期记忆(VLMT)和心理社会功能(GAF)方面有所改善,然而,只有后者在 2 年随访时显示出时间 x 研究/诊断的交互效应,表明在抑郁方面的预后显著优于精神分裂症。调节分析表明,在精神分裂症和情感障碍中,年龄、疾病持续时间或性别均不会导致心理社会和神经心理学功能发生变化。从再入院率来看,两种疾病之间没有显著差异。接受心理教育或心理教育与认知行为疗法相结合治疗的两组患者在神经心理学和心理社会功能以及对疾病的认识方面在 2 年随访时均有所改善,然而,与精神分裂症患者相比,重性抑郁症患者在心理社会功能方面的改善更为显著。讨论了这些发现的可能意义。